163 related articles for article (PubMed ID: 17393453)
1. Interleukin-6 and chemokines in the neuropsychiatric manifestations of systemic lupus erythematosus.
Fragoso-Loyo H; Richaud-Patin Y; Orozco-Narváez A; Dávila-Maldonado L; Atisha-Fregoso Y; Llorente L; Sánchez-Guerrero J
Arthritis Rheum; 2007 Apr; 56(4):1242-50. PubMed ID: 17393453
[TBL] [Abstract][Full Text] [Related]
2. Performance of eye sign combined with increased interleukin-6 in cerebrospinal fluid in patients with neuropsychiatric lupus erythematosus.
Shi LH; Liu ZY; Yu SJ; Xia Q; Zhao J; Wu R
Int J Rheum Dis; 2023 Aug; 26(8):1464-1473. PubMed ID: 37366596
[TBL] [Abstract][Full Text] [Related]
3. Correlation Between B-Cell Activating Factor of the Tumor Necrosis Factor Family Level in Serum and Immune Inflammation in Patients with Neuropsychiatric Systemic Lupus Erythematosus and its Clinical Value.
Pang J; Li Y; Tao R; Li J; Wang F; Xu H
Immunol Invest; 2024 May; 53(4):559-573. PubMed ID: 38329469
[TBL] [Abstract][Full Text] [Related]
4. Novel CSF biomarkers for diagnosis and integrated analysis of neuropsychiatric systemic lupus erythematosus: based on antibody profiling.
Ni J; Chen C; Wang S; Liu X; Tan L; Lu L; Fan Y; Hou Y; Dou H; Liang J
Arthritis Res Ther; 2023 Sep; 25(1):165. PubMed ID: 37684700
[TBL] [Abstract][Full Text] [Related]
5. Reduced homovanillic acid, SDF-1α and SCGF-β levels in cerebrospinal fluid are related to depressive states in systemic lupus erythematosus.
Fujita Y; Iwata S; Hidese S; Ishiwata S; Ide S; Tanaka H; Sonomoto K; Miyazaki Y; Nakayamada S; Ikenouchi A; Hattori K; Kunugi H; Yoshimura R; Tanaka Y
Rheumatology (Oxford); 2023 Oct; 62(10):3490-3500. PubMed ID: 36852847
[TBL] [Abstract][Full Text] [Related]
6. Neuropsychiatric lupus in late- and early-onset systemic lupus erythematosus patients: a systematic review and meta-analysis.
Pamuk ON; Raza AA; Hasni S
Rheumatology (Oxford); 2024 Jan; 63(1):8-15. PubMed ID: 37341643
[TBL] [Abstract][Full Text] [Related]
7. Microglia orchestrate synaptic and neuronal stripping: Implication in neuropsychiatric lupus.
Zhou Y; Chen L; Zheng X; Fang Q; Qian Y; Xu T; Liang J; Zhang H; Han X; Sun L
J Cell Mol Med; 2024 Apr; 28(7):e18190. PubMed ID: 38494844
[TBL] [Abstract][Full Text] [Related]
8. [Analysis of clinical characteristics and risk factors in patients with neuropsychiatric systemic lupus erythematosus (NPSLE)].
Liu J; Jia S; Wang P; Lyu T; Hu Y; Zhang Y
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2023 Oct; 39(10):924-927. PubMed ID: 37882716
[TBL] [Abstract][Full Text] [Related]
9. Animal models of neuropsychiatric systemic lupus erythematosus: deciphering the complexity and guiding therapeutic development.
Polis B; Cuda CM; Putterman C
Autoimmunity; 2024 Dec; 57(1):2330387. PubMed ID: 38555866
[TBL] [Abstract][Full Text] [Related]
10. Neuropsychiatric features of a cohort of patients with systemic lupus erythematosus.
Moraes-Fontes MF; Lúcio I; Santos C; Campos MM; Riso N; Vaz Riscado M
ISRN Rheumatol; 2012; 2012():989218. PubMed ID: 23227358
[TBL] [Abstract][Full Text] [Related]
11. Spatial enrichment of the type 1 interferon signature in the brain of a neuropsychiatric lupus murine model.
Aw E; Zhang Y; Yalcin E; Herrmann U; Lin SL; Langston K; Castrillon C; Ma M; Moffitt JR; Carroll MC
Brain Behav Immun; 2023 Nov; 114():511-522. PubMed ID: 37369340
[TBL] [Abstract][Full Text] [Related]
12. Elevated Serum Levels of Soluble Transferrin Receptor Are Associated with an Increased Risk of Cardiovascular, Pulmonary, and Hematological Manifestations and a Decreased Risk of Neuropsychiatric Manifestations in Systemic Lupus Erythematosus Patients.
Winikajtis-Burzyńska A; Brzosko M; Przepiera-Będzak H
Int J Mol Sci; 2023 Dec; 24(24):. PubMed ID: 38139169
[TBL] [Abstract][Full Text] [Related]
13. Th1-related transcription factors and cytokines in systemic lupus erythematosus.
Tang YY; Wang DC; Chen YY; Xu WD; Huang AF
Front Immunol; 2023; 14():1305590. PubMed ID: 38164134
[TBL] [Abstract][Full Text] [Related]
14. Role of IL-6 and IL-6 targeted therapy in systemic lupus erythematosus.
Nepal D; Gazeley D
Rheumatology (Oxford); 2023 Dec; 62(12):3804-3810. PubMed ID: 37594751
[TBL] [Abstract][Full Text] [Related]
15. Patterns of Local and Systemic Cytokines in Bacterial Meningitis and its Relation with Severity and Long-Term Sequelae.
Perdomo-Celis F; Torres MA; Ostos H; Gutierrez-Achury J; Molano V; Durán LF; González G; Narváez CF
Biomark Insights; 2015; 10():125-31. PubMed ID: 26715831
[TBL] [Abstract][Full Text] [Related]
16. Blood-brain barrier damages and intrathecal synthesis of anti-N-methyl-D-aspartate receptor NR2 antibodies in diffuse psychiatric/neuropsychological syndromes in systemic lupus erythematosus.
Hirohata S; Arinuma Y; Yanagida T; Yoshio T
Arthritis Res Ther; 2014 Mar; 16(2):R77. PubMed ID: 24655341
[TBL] [Abstract][Full Text] [Related]
17. Diagnosis and management of neuropsychiatric SLE.
Hanly JG
Nat Rev Rheumatol; 2014 Jun; 10(6):338-47. PubMed ID: 24514913
[TBL] [Abstract][Full Text] [Related]
18. Role of Serum IL-6 in Neuropsychiatric Systemic lupus Erythematosus.
Hirohata S; Kikuchi H
ACR Open Rheumatol; 2021 Jan; 3(1):42-49. PubMed ID: 33393227
[TBL] [Abstract][Full Text] [Related]
19. IL-6, IL-8, IP-10, MCP-1 and G-CSF are significantly increased in cerebrospinal fluid but not in sera of patients with central neuropsychiatric lupus erythematosus.
Yoshio T; Okamoto H; Kurasawa K; Dei Y; Hirohata S; Minota S
Lupus; 2016 Aug; 25(9):997-1003. PubMed ID: 26846690
[TBL] [Abstract][Full Text] [Related]
20. Potent induction of IFN-alpha and chemokines by autoantibodies in the cerebrospinal fluid of patients with neuropsychiatric lupus.
Santer DM; Yoshio T; Minota S; Möller T; Elkon KB
J Immunol; 2009 Jan; 182(2):1192-201. PubMed ID: 19124763
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
